The trading price of UnitedHealth Group Incorporated (NYSE:UNH) closed higher on Tuesday, July 20, closing at $412.97, 0.96% higher than its previous close.
Traders who pay close attention to intraday price movement should know that it fluctuated between $410.61 and $417.73. The company’s P/E ratio in the trailing 12-month period was 27.27, while its 5Y monthly beta was 0.78. In examining the 52-week price action we see that the stock hit a 52-week high of $425.98 and a 52-week low of $289.64. Over the past month, the stock has gained 6.06% in value.
UnitedHealth Group Incorporated, whose market valuation is $390.05 billion at the time of this writing, is expected to release its quarterly earnings report Oct 12, 2021 – Oct 18, 2021. The dividend yield on the company stock is 1.40%, while its Forward Dividend ratio is 5.80. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by $4.43 per share this quarter, however they have predicted annual earnings per share of $18.57 for 2021 and $21.37 for 2022. It means analysts are expecting annual earnings per share growth of 10.00% this year and 15.10% next year.
Analysts have forecast the company to bring in revenue of $69.6 billion for the current quarter, with the likely lows of $67.31 billion and highs of $70.73 billion. From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue in 2021 is $281.33 billion. The company’s revenue is forecast to grow by 9.40% over what it did in 2021.
A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of UnitedHealth Group Incorporated No upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest UNH has a 100% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Buy, while an average of long term indicators suggests that the stock is currently 100% Buy.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned UNH a recommendation rating is 28. Out of them, 3 rate it a Hold, while 23 recommend Buy, whereas 1 assign an Overweight rating. 1 analyst(s) have tagged UnitedHealth Group Incorporated (UNH) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
If we dig deeper into the stock’s outlook, we see that the stock’s PEG is 2.11, which symbolizes a positive outlook. A quick review shows that UNH’s price is currently 1.31% off the SMA20 and 1.47% off the SMA50. The RSI metric on the 14-day chart is currently showing 54.67, and weekly volatility stands at 2.35%. When measured over the past 30 days, the indicator reaches 1.61%. UnitedHealth Group Incorporated (NYSE:UNH)’s beta value is currently sitting at 0.78, while the Average True Range indicator is currently displaying 7.04. With analysts defining $360.00-$522.00 as the low and high price targets, we arrive at a consensus price target of $459.13 for the trailing 12-month period. The current price is about 12.83% off the estimated low and -26.4% off the forecast high, based on this estimate. Investors will be thrilled if UNH’s share price rises to $457.50, which is the median consensus price. At that level, UNH’s share price would be -10.78% below current price.
To see how UnitedHealth Group Incorporated stock has been performing in comparison to its peers in the industry, here are the numbers: UNH stock’s performance was 0.96% in the latest trading, and 36.09% in the past year, while Humana Inc. (HUM) has traded -0.09% on the day and positioned 16.07% higher than it was a year ago. Another comparable company Anthem Inc. (ANTM) saw its stock close 1.43% higher in the most recent trading session but was up 50.56% in a year. Furthermore, Centene Corporation (CNC) showed an increase of 0.42% on the day while its price kept inclining at 10.50% over the past year. UnitedHealth Group Incorporated has a P/E ratio of 27.27, compared to Humana Inc.’s 16.38 and Anthem Inc.’s 20.87. Also in last trading session, the S&P 500 Index has surged 1.52%, while the Dow Jones Industrial also saw a positive session, up 1.62% on the day.
An evaluation of the daily trading volume of UnitedHealth Group Incorporated (NYSE:UNH) indicates that the 3-month average is 2.96 million. However, this figure has increased over the past 10 days to an average of 3.09 million.
Currently, records show that 945.00 million of the company’s shares remain outstanding. The insiders hold 0.20% of outstanding shares, whereas institutions hold 89.10%. The stats also highlight that short interest as of Jun 14, 2021, stood at 6.4 million shares, resulting in a short ratio of 2.46 at that time. From this, we can conclude that short interest is 0.68% of the company’s total outstanding shares. It is noteworthy that short shares in June were down slightly from the previous month’s figure, which was 6.88 million. However, since the stock’s price has seen 17.76% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.